IBDEI0XN ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16611,1,4,0)
 ;;=4^174.9
 ;;^UTILITY(U,$J,358.3,16611,1,5,0)
 ;;=5^Ca Breast
 ;;^UTILITY(U,$J,358.3,16611,2)
 ;;=Breast CA^267202
 ;;^UTILITY(U,$J,358.3,16612,0)
 ;;=176.9^^92^940^87
 ;;^UTILITY(U,$J,358.3,16612,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16612,1,4,0)
 ;;=4^176.9
 ;;^UTILITY(U,$J,358.3,16612,1,5,0)
 ;;=5^Kaposi's Sarcoma
 ;;^UTILITY(U,$J,358.3,16612,2)
 ;;=Kaposi's Sarcoma^107993
 ;;^UTILITY(U,$J,358.3,16613,0)
 ;;=172.9^^92^940^94
 ;;^UTILITY(U,$J,358.3,16613,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16613,1,4,0)
 ;;=4^172.9
 ;;^UTILITY(U,$J,358.3,16613,1,5,0)
 ;;=5^Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,16613,2)
 ;;=^75462
 ;;^UTILITY(U,$J,358.3,16614,0)
 ;;=185.^^92^940^46
 ;;^UTILITY(U,$J,358.3,16614,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16614,1,4,0)
 ;;=4^185.
 ;;^UTILITY(U,$J,358.3,16614,1,5,0)
 ;;=5^Ca Prostate
 ;;^UTILITY(U,$J,358.3,16614,2)
 ;;=Prostate CA^99481
 ;;^UTILITY(U,$J,358.3,16615,0)
 ;;=189.0^^92^940^48
 ;;^UTILITY(U,$J,358.3,16615,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16615,1,4,0)
 ;;=4^189.0
 ;;^UTILITY(U,$J,358.3,16615,1,5,0)
 ;;=5^Ca Renal
 ;;^UTILITY(U,$J,358.3,16615,2)
 ;;=Renal Cancer^73523
 ;;^UTILITY(U,$J,358.3,16616,0)
 ;;=189.1^^92^940^49
 ;;^UTILITY(U,$J,358.3,16616,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16616,1,4,0)
 ;;=4^189.1
 ;;^UTILITY(U,$J,358.3,16616,1,5,0)
 ;;=5^Ca Renal Pelvis
 ;;^UTILITY(U,$J,358.3,16616,2)
 ;;=   ^267264
 ;;^UTILITY(U,$J,358.3,16617,0)
 ;;=171.9^^92^940^113
 ;;^UTILITY(U,$J,358.3,16617,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16617,1,4,0)
 ;;=4^171.9
 ;;^UTILITY(U,$J,358.3,16617,1,5,0)
 ;;=5^Soft Tissue Sarcoma
 ;;^UTILITY(U,$J,358.3,16617,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,16618,0)
 ;;=186.9^^92^940^52
 ;;^UTILITY(U,$J,358.3,16618,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16618,1,4,0)
 ;;=4^186.9
 ;;^UTILITY(U,$J,358.3,16618,1,5,0)
 ;;=5^Ca Testicular
 ;;^UTILITY(U,$J,358.3,16618,2)
 ;;=^267242
 ;;^UTILITY(U,$J,358.3,16619,0)
 ;;=198.7^^92^940^7
 ;;^UTILITY(U,$J,358.3,16619,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16619,1,4,0)
 ;;=4^198.7
 ;;^UTILITY(U,$J,358.3,16619,1,5,0)
 ;;=5^Adrenal Metastasis
 ;;^UTILITY(U,$J,358.3,16619,2)
 ;;=^267337
 ;;^UTILITY(U,$J,358.3,16620,0)
 ;;=198.5^^92^940^95
 ;;^UTILITY(U,$J,358.3,16620,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16620,1,4,0)
 ;;=4^198.5
 ;;^UTILITY(U,$J,358.3,16620,1,5,0)
 ;;=5^Mets to Bone or Bone Marrow
 ;;^UTILITY(U,$J,358.3,16620,2)
 ;;=^267336
 ;;^UTILITY(U,$J,358.3,16621,0)
 ;;=198.3^^92^940^96
 ;;^UTILITY(U,$J,358.3,16621,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16621,1,4,0)
 ;;=4^198.3
 ;;^UTILITY(U,$J,358.3,16621,1,5,0)
 ;;=5^Mets to Brain
 ;;^UTILITY(U,$J,358.3,16621,2)
 ;;=Brain Metatastasis^267334
 ;;^UTILITY(U,$J,358.3,16622,0)
 ;;=197.7^^92^940^39
 ;;^UTILITY(U,$J,358.3,16622,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16622,1,4,0)
 ;;=4^197.7
 ;;^UTILITY(U,$J,358.3,16622,1,5,0)
 ;;=5^Ca Liver, Secondary
 ;;^UTILITY(U,$J,358.3,16622,2)
 ;;=CA Liver, Secondary^267328
 ;;^UTILITY(U,$J,358.3,16623,0)
 ;;=197.0^^92^940^97
 ;;^UTILITY(U,$J,358.3,16623,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16623,1,4,0)
 ;;=4^197.0
 ;;^UTILITY(U,$J,358.3,16623,1,5,0)
 ;;=5^Mets to Lung
 ;;^UTILITY(U,$J,358.3,16623,2)
 ;;=Mets to Lung^267322
 ;;^UTILITY(U,$J,358.3,16624,0)
 ;;=196.2^^92^940^98
 ;;^UTILITY(U,$J,358.3,16624,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,16624,1,4,0)
 ;;=4^196.2
 ;;^UTILITY(U,$J,358.3,16624,1,5,0)
 ;;=5^Mets to Lymph Nodes,Abdominal
 ;;^UTILITY(U,$J,358.3,16624,2)
 ;;=^267316
